Retinal Screening Before GLP-1 Therapy
Independent Ocular Risk Assessment
SKEYE offers standalone retinal screening for patients and providers seeking baseline ocular documentation before starting GLP-1 medications.
This service supports proactive, responsible care by evaluating optic nerve and retinal health prior to treatment.
Two Screening Options
Option 1: In-Clinic Retinal Screening
$85
For patients who prefer in-person evaluation
Includes:
High-resolution retinal imaging
Optic nerve and retinal assessment
Review by a licensed optometrist
Written screening summary
Best for:
Patients without recent retinal imaging
Clinics referring patients for baseline documentation
Individuals seeking direct evaluation
Option 2: Remote Retinal Image Review
$60
For patients or clinics with existing retinal images
Includes:
Secure submission of retinal photographs
Review by a licensed optometrist
Written screening summary
Requirements:
Images must be recent and of diagnostic quality
Not all images may be eligible for review
Best for:
Wellness clinics with imaging equipment
Patients who already have retinal photos
Remote or out-of-state screening needs
What This Screening Provides
Baseline documentation of optic nerve and retinal health
Identification of findings that may warrant monitoring or referral
Objective ocular insight prior to GLP-1 therapy
Important Notes
This is a screening, not a comprehensive eye exam
This service does not determine GLP-1 eligibility
No prescriptions are provided
Findings may prompt recommendations for further evaluation if indicated
